Eclipse 4 (Canada)

Feline Rhinotracheitis-calici-panleukopenia-chlamydia Psittaci vaccine

MODIFIED LIVE VIRUS AND CHLAMYDIA

For veterinary use in cats only

Product Description

Eclipse^® 4 vaccine is a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci.

Eclipse 4 Dosage And Administration

Transfer contents of the diluent vial to the Eclipse 4 vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination. Annual revaccination with one dose is recommended.

Precautions

- Store at 2°-7°C.

- Do not freeze.

- Do not mix with other vaccines.

- Use new, non-chemically sterilized needles and syringes.

- Burn vaccine container and all unused contents.

Warnings

- Contains gentamicin as a preservative.

- Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.

- Do not vaccinate pregnant cats.

- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote

U.S. Veterinary License No. 165A

Schering-Plough Animal Health Corporation, Omaha, NE 68103 USA

1 800 224-5318 (USA)

1 888 306-0069 (Canada)

© Copyright 1999, 2001, 2006, Schering-Plough Animal Health Corp. All rights reserved.

^® Registered trademark of Schering-Plough Canada Inc.

Nac No.